PMA P950034S005

Device
SEPRAFILM BIORESORBABLE MEMBRANE
Applicant
Baxter Healthcare Corporation
PMA number
P950034
Supplement
S005
Product code
MCN
Decision date
1998-02-25
Generic name
Barrier, absorbable, adhesion
Approval order statement
In this supplment the applicant agrees to submit an Investigational Device Exemptions (IDE) application for the modified postapproval safety study, is approved. We believe that this study, with the modifications as discussed, will satisfy the condition ofapproval for this PMA, but we may have additional comments on the IDE botha s it related to the objectives of the postapproval study, depending on your responses, and your objective of collecting outcomes data on the incidence of small bowel obstruction.

Current openFDA PMA Record#

Device
SEPRAFILM BIORESORBABLE MEMBRANE
Applicant
Baxter Healthcare Corporation
PMA number
P950034
Supplement
S005
Product code
MCN
Generic name
Barrier, absorbable, adhesion
Decision date
1998-02-25
Decision code
APPR
Date received
1997-04-16
Supplement type
Real-Time Process
Supplement reason
Postapproval Study Protocol
Approval order statement
In this supplment the applicant agrees to submit an Investigational Device Exemptions (IDE) application for the modified postapproval safety study, is approved. We believe that this study, with the modifications as discussed, will satisfy the condition ofapproval for this PMA, but we may have additional comments on the IDE botha s it related to the objectives of the postapproval study, depending on your responses, and your objective of collecting outcomes data on the incidence of small bowel obstruction.